The Douglas Institute is part of an international effort to investigate a new treatment A vaccine-based approach could be an effective therapy for people with mild or moderate forms of Alzheimer’s disease. The medication used for this therapy w

McGill, MUHC and Douglas researchers, among them Alain Brunet, get top marks from Québec Science

Over the past 2 years, the Douglas has been working on a project to renew its physical infrastructure. This process has been driven by the increasing number of obstacles the aging facilities present to delivering against the organization’s multi

Building Together the Institute: 2007-2008 Annual Report

The Douglas Institute recently inaugurated its new Neurophenotyping Centre.

Douglas’ director of the Eating Disorders Program hosts international meeting

45 trees of varying species have been planted at the campus to improve the quality of life for visitors.

Ice Storm Babies: Where are they now? Douglas’ researchers assess their development at 5 ½ years of age.

The current reorganization of mental health services is no small affair. It brings sweeping changes to Quebec’s healthcare system and will affect each and every one of us.

Early diagnosis of Alzheimer?s disease - New criteria ready to be validated